A new rapid molecular point-of-care assay for Trichomonas vaginalis: preliminary performance data (Pearce, D. M. et al. 2013)

  • Tuesday, 16 April 2013
  • in News

Sexually Transmitted Infections; 89: 495-497.

Trichomonas vaginalis infection is the most prevalent treatable sexually transmitted infection (STI) in the world. An accurate point-of-care (PoC) molecular test would enable patients to be tested and treated for T vaginalis in a single visit to the genitourinary medicine clinic, community STI clinic, pharmacy or doctor’s office. In this report, we describe a rapid prototype assay for T vaginalis designed for use in conjunction with the Atlas io® PoC platform, and initial verification of its performance using 90 clinical samples.

Read 592 times